Infection control in the post-antibiotic era

Healthcare Infection

Volumn 18, Issue 2, 2013, Pages 51-60

  Dancer, Stephanie J ^a  

^a HAIRMYRES HOSPITAL   (United Kingdom)

Author keywords

antimicrobial stewardship; decontamination; healthcare associated infection; hospital hygiene; infection control

Indexed keywords

AIRBORNE INFECTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL THERAPY; CLINICAL PRACTICE; CROSS RESISTANCE; ELECTRONIC PRESCRIBING; FOOD CHAIN; HAND WASHING; HEALTH CARE DELIVERY; HEALTH CARE PERSONNEL; HEALTH CARE POLICY; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL; HUMAN; INFECTION CONTROL; INFECTION CONTROL PRACTITIONER; INFECTION PREVENTION; INTERNATIONAL COOPERATION; LIVESTOCK; MEDICAL DEVICE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PRACTICE GUIDELINE; REVIEW; SEWAGE; VETERINARY MEDICINE; WASTE DISPOSAL; WASTE MANAGEMENT;

EID: 84878277034     PISSN: 18355617     EISSN: 18355625     Source Type: Journal    
DOI: 10.1071/HI12042     Document Type: Review

References (136)

1. Macias AE, Ponce-de-Leon S. Infection control: old problems and new challenges. Arch Med Res 2005; 36: 637-45. doi:10.1016/j. arcmed.2005.05.004 (Pubitemid 41436233)
2. Gastmeier P. Healthcare-associated versus community-acquired infections: a newchallenge for science and society. Int JMedMicrobiol 2010; 300: 342-5. doi:10.1016/j.ijmm.2010.04.007
3. Sydnor ER, Perl TM. Hospital epidemiology and infection control in acute-care settings. Clin Microbiol Rev 2011; 24: 141-73. doi:10.1128/CMR.00027- 10
4. Wilson ME, Chen LH. NDM-1 and the role of travel in its dissemination. Curr Infect Dis Rep 2012; 14: 213-26. doi:10.1007/s11908-012-0252-x
5. Carlet J, Collignon P, Goldmann D, Goossens H, Gyssens IC, Harbarth S, et al. Society's failure to protect a precious resource: antibiotics. Lancet 2011; 378: 369-71. doi:10.1016/S0140-6736(11)60401-7
6. Chan M. Antimicrobial resistance: no action today means no cure tomorrow. Geneva, Switzerland: World Health Organization; 2011. Available from: http://www.who.int/dg/speeches/2011/WHD- 20110407/en/index.html [verified 22 March 2013].
7. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81. doi:10.1111/j.1469-0691.2011.03570.x
8. Clements AC, Magalhães RJ, Tatem AJ, Paterson DL, Riley TV. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect Dis 2010; 10: 395-404. doi:10.1016/S1473-3099(10)70080-3
9. Baines SD, O'Connor R, Freeman J, Fawley WN, Harmanus C, Mastrantonio P, et al. Emergence of reduced susceptibility to metronidazole in Clostridium difficile. J Antimicrob Chemother 2008; 62: 1046-52. doi:10.1093/jac/dkn313
10. WangB, Taylor J, Ratnamohan M, McPhie K, Kesson A, Dixit R, et al. Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A (H1N1)pdm09 virus, Australia, June to August 2011. Euro Surveill 2012; 17: 20 210.
11. Marshall JA, Bruggink LD. The dynamics of norovirus outbreak epidemics: recent insights. Int J Environ Res Public Health 2011; 8: 1141-9. doi:10.3390/ijerph8041141
12. Osterholm MT. Preparing for the next pandemic. N Engl J Med 2005; 352: 1839-42. doi:10.1056/NEJMp058068 (Pubitemid 40627807)
13. Freire-Moran L, Aronsson B, Manz C, Gyssens IC, So AD, Monnet DL, et al. ECDC-EMA Working GroupCritical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now. Drug Resist Updat 2011; 14: 118-24. doi:10.1016/j. drup.2011.02.003
14. Theuretzbacher U. Accelerating resistance, inadequate antibacterial drug pipelines and international responses. Int J Antimicrob Agents 2012; 39: 295-9. doi:10.1016/j.ijantimicag.2011.12.006
15. Cormican M, Vellinga A. Existing classes of antibiotics are probably the best we will ever have. BMJ 2012; 344: e3369. doi:10.1136/bmj. e3369
16. Appelbaum PC. 2012 and beyond: potential for the start of a second pre-antibiotic era? J Antimicrob Chemother 2012; 67: 2062-8. doi:10.1093/jac/dks213
17. Carlet JM, Jarlier V, Harbarth S, Voss A, Goossens H, Pittet D, et al. Ready for a world without antibiotics? The Pensieres antibiotic resistance call to action. Antimicrob Resist Infect Control 2012; 1: 11. doi:10.1186/2047-2994- 1-11
18. Dettenkofer M, Ammon A, Astagneau P, Dancer SJ, Gastmeier P, Harbarth S, et al. Infection control-a European research perspective for the next decade. Report from a symposium held in Freiburg, Germany. J Hosp Infect 2011; 77: 7-10. doi:10.1016/j.jhin.2010.
19. Delepierre A, Gayot A, Carpentier A. Update on counterfeit antibiotics worldwide; Public health risks. Med Mal Infect 2012; 42: 247-55.
20. Marwick C, Davey P. Care bundles: the holy grail of infectious risk management in hospital? Curr Opin Infect Dis 2009; 22: 364-9. doi:10.1097/QCO.0b013e32832e0736
21. Bull A, Wilson J, Worth LJ, Stuart RL, Gillespie E,WaxmanB, et al.A bundle of care to reduce colorectal surgical infections: an Australian experience. J Hosp Infect 2011; 78: 297-301. doi:10.1016/j.jhin. 2011.03.029
22. Anthony T, Murray BW, Sum-Ping JT, Lenkovsky F, Vornik VD, Parker BJ, et al. Evaluating an evidence-based bundle for preventing surgical site infection: a randomized trial. Arch Surg 2011; 146: 263-9. doi:10.1001/archsurg.2010.249
23. Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. J Antimicrob Chemother 2007; 59: 833-40. doi:10.1093/jac/dkm055 (Pubitemid 47073352)
24. Gould D, Chamberlain A. The use of a ward-based educational teaching package to enhance nurses' compliance with infection control procedures. J Clin Nurs 1997; 6: 55-67. doi:10.1111/j.1365-2702.1997.tb00284.x (Pubitemid 127731563)
25. Cocanour CS, Peninger M, Domonoske BD, Li T, Wright B, Valdivia A, et al. Decreasing ventilator-associated pneumonia in a trauma ICU. J Trauma 2006; 61: 122-30. doi:10.1097/01.ta.0000223971. 25845.b3 (Pubitemid 44098329)
26. Cimiotti JP, Aiken LH, Sloane DM, Wu ES. Nurse staffing, burnout, and healthcare-associated infection. Am J Infect Control 2012; 40: 486-90. doi:10.1016/j.ajic.2012.02.029
27. Dancer SJ. Infection control from the other side: a patient's perspective. J Hosp Infect 2012; 80: 189-91. doi:10.1016/j.jhin.2011.12.003
28. Beggs CB, Noakes CJ, Shepherd SJ, Kerr KG, Sleigh PA, Banfield K. The influence of nurse cohorting on hand hygiene effectiveness. Am J Infect Control 2006; 34: 621-6. doi:10.1016/j.ajic.2006.06.011 (Pubitemid 44856040)
29. Smith SJ, Young V, Robertson C, Dancer SJ. Cross-transmission audit of environmental surfaces, clinical equipment and patient: who touches what? J Hosp Infect 2012; 80: 206-11. doi:10.1016/j.jhin. 2011.12.007
30. Owens RC Jr, Shorr AF, Deschambeault AL. Antimicrobial stewardship: shepherding precious resources. Am J Health Syst Pharm 2009; 66(12): S15-22. doi:10.2146/090087c
31. Rampling A, Wiseman S, Davis L, Hyett AP, Walbridge AN, Payne GC, et al. Evidence that hospital hygiene is important in the control of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2001; 49: 109-16. doi:10.1053/jhin.2001.1013 (Pubitemid 32982684)
32. Mehtar S. How to cost and fund an infection control programme. J Hosp Infect 1993; 25: 57-69. doi:10.1016/0195-6701(93)90009-O (Pubitemid 23301509)
33. Clements A, Halton K, Graves N, Pettitt A, Morton A, Looke D, et al. Overcrowding and understaffing in modern health-care systems: key determinants in meticillin-resistant Staphylococcus aureus transmission. Lancet Infect Dis 2008; 8: 427-34. doi:10.1016/S1473-3099(08)70151-8 (Pubitemid 351863737)
34. Lim S, Closson T, Howard G, Gardam M. Collateral damage: the unforeseen effects of emergency outbreak policies. Lancet Infect Dis 2004; 4: 697-703. doi:10.1016/S1473-3099(04)01176-4 (Pubitemid 39452523)
35. Kaier K, Mutters NT, Frank U. Bed occupancy rates and hospitalacquired infections-should beds be kept empty? Clin Microbiol Infect 2012; 18: 941-5. doi:10.1111/j.1469-0691.2012.03956.x
36. National Institute for Health&Clinical Excellence (NICE). Prevention and control of healthcare-associated infections: quality improvement guide. London: NICE; 2011. Available from: http://publications.nice. org.uk/prevention-and-control-of-healthcare-associated-infectionsph36 [verified 22 March 2013]
37. Borg MA. Could the incidence of healthcare infections in Europe simply be a reflection of overall quality standards? J Hosp Infect 2012; 82: 141-2. doi:10.1016/j.jhin.2012.07.016
38. Larsen MV, Cosentino S, Rasmussen S, Friis C, Hasman H, Marvig RL, et al. Multilocus sequence typing of total-genome-sequenced bacteria. J Clin Microbiol 2012; 50: 1355-61. doi:10.1128/JCM. 06094-11
39. Burke L, Humphreys H, Fitzgerald-Hughes D. The revolving door between hospital and community: extended-spectrum beta-lactamaseproducing Escherichia coli in Dublin. J Hosp Infect 2012; 81: 192-8. doi:10.1016/j.jhin.2012.04.021
40. Denkinger CM, Grant AD, Denkinger M, Gautam S, D'Agata EMC. Increased multidrug resistance among the elderly on admission to the hospital-a 12 year surveillance study. Arch Gerontol Geriatr 2013; 56: 227-30. doi:10.1016/j. archger.2012.05.006
41. Touati A, Zenati K, Brasme L, Benallaoua S, de Champs C. Extendedspectrum beta-lactamase characterisation and heavy metal resistance of Enterobacteriaceae strains isolated from hospital environmental surfaces. J Hosp Infect 2010; 75: 78-9. doi:10.1016/j.jhin.2010.
42. Skov R, Christiansen K, Dancer SJ, Daum RS, Dryden M, Huang YC, et al. Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). Int J Antimicrob Agents 2012; 39: 193-200. doi:10.1016/j.ijantimicag. 2011.09.029
43. van den Bogaard AE, Stobberingh EE. Epidemiology of resistance to antibiotics; links between animals and humans. Int J Antimicrob Agents 2000; 14: 327-35. doi:10.1016/S0924-8579(00)00145-X (Pubitemid 30224497)
44. Verheij TJ. The antibiotic revolution should be more focused. Br J Gen Pract 2009; 59: 716-7. doi:10.3399/bjgp09X472557
45. Kieran I, LyttleM, LeroiM.Successful antibiotic stewardship: arewea victim of our own success? ANZ J Surg 2011; 81: 488-9. doi:10.1111/j.1445-2197. 2011.05775.x
46. Dancer SJ. How antibiotics can make us sick. Review of the lesserknown adverse effects of antibiotic chemotherapy. Lancet Infect Dis 2004; 4: 611-9. doi:10.1016/S1473-3099(04)01145-4 (Pubitemid 39296835)
47. Levy SB. Antibacterial household products: cause for concern. Emerg Infect Dis 2001; 7: 512-5. doi:10.3201/eid0707.017705 (Pubitemid 32726819)
48. Sattar SA. Reducing the health impact of infectious agents: the significance of preventive strategies. GMS Krankenhhyg Interdiszip 2007; 2(1): Doc06.
49. D'Arcy N. Antimicrobials in plastics: a global review. Plast Addit Compd 2001; 3: 12-5. doi:10.1016/S1464-391X(01)80328-7
50. Braid JJ, Wale MCJ. The antibacterial activity of triclosanimpregnated storage boxes against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Bacillus cereus and Shewanella putrefaciens in conditions simulating domestic use. J Antimicrob Chemother 2002; 49: 87-94. doi:10.1093/jac/49.1.87 (Pubitemid 34100650)
51. Aiello AE, Larson EL, Levy SB. Consumer antibacterial soaps: effective or just risky? Clin Infect Dis 2007; 45: S137-47. doi:10.1086/519255 (Pubitemid 47328628)
52. AkimitsuN,HamamotoH, Inoue R, ShojiM,AkamineA, Takemori K, et al. Increase in resistance of methicillin-resistant Staphylococcus aureus to beta-lactams caused by mutations conferring resistance to benzalkonium chloride, a disinfectant widely used in hospitals. Antimicrob Agents Chemother 1999; 43: 3042-3.
53. Naparstek L, Carmeli Y, Chmelnitsky I, Banin E, Navon-Venezia S. Reduced susceptibility to chlorhexidine among extremely-drugresistant strains of Klebsiella pneumoniae. J Hosp Infect 2012; 81: 15-9. doi:10.1016/j.jhin.2012.02. 007
54. Curtis V, Schmidt W, Luby S, Florez R, Touré O, Biran A. Hygiene: new hopes, new horizons. Lancet Infect Dis 2011; 11: 312-21. doi:10.1016/S1473-3099(10)70224-3
55. Silva J, Castillo G, Callejas L, Lopez H, Olmos J. Frequency of transferable multiple antibiotic resistance among coliform bacteria isolated from a treated sewage effluent in Antofagasta, Chile. Electron J Biotechnol 2006; 9: 534-40. doi:10.2225/vol9-issue5-fulltext-7 (Pubitemid 44663131)
56. Gandhi NR,Nunn P, Dheda K, Schaaf HS, ZignolM, van Soolingen D, et al. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 2010; 375: 1830-43. doi:10.1016/S0140- 6736(10)60410-2
57. Kobaidze K, Salakaia A, Blumberg HM. Over the counter availability of antituberculosis drugs in Tbilisi, Georgia in the setting of a high prevalence of MDR-TB. Interdiscip Perspect Infect Dis 2009; 2009: 513 609. doi:10.1155/2009/513609
58. Khan AU, Nordmann P. Spread of carbapenemase NDM-1 producers: the situation in India and what may be proposed. Scand J Infect Dis 2012; 44: 531-5. doi:10.3109/00365548.2012.669046
59. Zarb P, Goossens H. Human use of antimicrobial agents. Rev Sci Tech 2012; 31: 121-33.
60. Young JH. The Toadstool Millionaires: A Social History of Patent Medicines in America before Federal Regulation. Princeton, NJ: Princeton University Press; 1961.
61. Calva JJ, Sifuentes-Osornio J, Ceron C. Antimicrobial resistance in fecal flora: longitudinal community based surveillance of children from urban Mexico. Antimicrob Agents Chemother 1996; 40: 1699-702. (Pubitemid 26227360)
62. French GL, Ling J, Chow KL, Mark KK. Occurrence of multiple antibiotic resistance and R-plasmids in gram-negative bacteria isolated from faecally contaminated fresh-water streams in Hong Kong. Epidemiol Infect 1987; 98: 285-99. doi:10.1017/S095026880006204X (Pubitemid 18079280)
63. Smith DL, Harris AD, Johnson JA. Animal antibiotic use has an early but important impact on the emergence of antibiotic resistance in human commensal bacteria. Proc Natl Acad Sci USA 2002; 99: 6434-9. doi:10.1073/pnas.082188899 (Pubitemid 34493329)
64. Levy SB, Fitzgerald GB, Macone AB. Changes in intestinal flora of farm personnel after introduction of a tetracycline-supplemented feed on a farm. N Engl J Med 1976; 295: 583-8. doi:10.1056/NEJM197609092951103
65. Price LB, Stegger M, Hasman H, Aziz M, Larsen J, Andersen PS, et al. Staphylococcus aureus CC398: host adaptation and emergence of methicillin resistance in livestock. MBiol 2012; 3: e00 305-11.
66. van den Bogaard AE, London N, Driessen C, Stobberingh EE. Antibiotic resistance of faecal Escherichia coli in poultry, poultry farmers and poultry slaughterers. J Antimicrob Chemother 2001; 47: 763-71. doi:10.1093/jac/47.6.763 (Pubitemid 32519824)
67. Warren RE, Ensor VM, O'Neill P, Butler V, Taylor J, Nye K, et al. Imported chicken meat as a potential source of quinolone-resistant Escherichia coli producing extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2008; 61: 504-8. doi:10.1093/jac/dkm517 (Pubitemid 351321121)
68. FDA. Guidance for industry: The judicious use of medically important antimicrobial drugs in food-producing animals. Rockville, MD: Food and Drug Administration; 2012. Available from: http://www.fda.gov/downloads/ AnimalVeterinary/GuidanceComplianceEnforcement/GuidanceforIndustry/UCM216936. pdf [verified 22 March 2013]
69. Marshall M. Farmyard antibiotics linked to superbugs. New Scientist 2012; 2853: 22 February.
70. Bergström K, NymanG, Widgren S, Johnston C, Grönlund-Andersson U, Ransjö U. Infection prevention and control interventions in the first outbreak of methicillin-resistant Staphylococcus aureus infections in an equine hospital in Sweden. Acta Vet Scand 2012; 54: 14. doi:10.1186/1751-0147-54-14
71. Sieber S, Gerber V, Jandova V, Rossano A, Evison JM, Perreten V. Evolution of multidrug-resistant Staphylococcus aureus infections in horses and colonized personnel in an equine clinic between 2005 and 2010. Microb Drug Resist 2011; 17: 471-8. doi:10.1089/mdr. 2010.0188
72. Catry B, Van Duijkeren E, Pomba MC, Greko C, Moreno MA, Pyörälä S, et al. Scientific Advisory Group on Antimicrobials (SAGAM) Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health. Epidemiol Infect 2010; 138: 626-44. doi:10.1017/S0950268810000014
73. WegenerHC. Danish initiatives to improve the safety of meat products. Meat Sci 2010; 84: 276-83. doi:10.1016/j.meatsci.2009.06.025
74. Damani N. Manual of Infection Prevention and Control. 3rd edn. Oxford, UK: Oxford University Press; 2012.
75. Cheng VC, Tai JW, Ho SK, Chan JF, Hung KN, Ho PL, et al. Introduction of an electronic monitoring system for monitoring compliance with Moments 1 and 4 of the WHO "My 5 Moments for Hand Hygiene" methodology. BMC Infect Dis 2011; 11: 151. doi:10.1186/1471-2334-11-151
76. Dancer SJ. Mopping up hospital infection. J Hosp Infect 1999; 43: 85-100. doi:10.1053/jhin.1999.0616 (Pubitemid 29460425)
77. Vickery K, Deva A, Jacombs A, Allan J, Valente P, Gosbell IB. Presence of biofilm containing viable multiresistant organisms despite terminal cleaning on clinical surfaces in an intensive care unit. J Hosp Infect 2012; 80: 52-5. doi:10.1016/j.jhin.2011.07.007
78. Dancer SJ. Hospital cleaning in the 21st Century. Eur J Clin Microbiol Infect Dis 2011; 30: 1473-81. doi:10.1007/s10096-011-1250-x
79. Dancer SJ. How do we assess hospital cleaning? A proposal for microbiological standards for surface hygiene in hospitals. J Hosp Infect 2004; 56: 10-5. doi:10.1016/j.jhin.2003.09.017 (Pubitemid 38029109)
80. Griffith C. HACCP and the management of healthcare associated infections: are there lessons to be learnt from other industries? Int J Health Care Qual Assur Inc Leadersh Health Serv 2006; 19: 351-67. doi:10.1108/09526860610671409 (Pubitemid 43992790)
81. Anderson RE, Young V, Stewart M, Robertson C, Dancer SJ. Cleanliness audit of clinical surfaces and equipment:Whocleans what? J Hosp Infect 2011; 78: 178-81. doi:10.1016/j.jhin.2011.01.030
82. Moore G, Ali S, FitzGerald G, MuzslayM, Atkinson S, Smith S, et al. SmartIdeas Research Student Group, Wilson AP. Ward assessment of SmartIdeas project: bringing source isolation to the patient. J Hosp Infect 2010; 76: 103-7. doi:10.1016/j.jhin.2010.04.017
83. Maclean M, MacGregor SJ, Anderson JG, Woolsey GA, Coia JE, Hamilton K, et al. Environmental decontamination of a hospital isolation room using high-intensity narrow-spectrum light. J Hosp Infect 2010; 76: 247-51. doi:10.1016/j.jhin.2010.07.010
84. Saint S, Elmore JG, Sullivan SD, Emerson SS, Koepsell TD. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998; 105: 236-41. doi:10.1016/S0002-9343(98)00240-X (Pubitemid 28443213)
85. Falagas ME, Thomaidis PC, Kotsantis IK, Sgouros K, Samonis G, Karageorgopoulos DE. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 2011; 78: 171-7. doi:10.1016/j.jhin.2010.12.006
86. Meakin NS, Bowman C, Lewis M, Dancer SJ. Cleaning efficacy between in-use disinfectant and electrolysed water in an English residential care home. J Hosp Infect 2012; 80: 122-7. doi:10.1016/j. jhin.2011.10.015
87. Escombe AR, Oeser CC, Gilman RH, Navincopa M, Ticona E, Pan W, et al. Natural ventilation for the prevention of airborne contagion. PLoS Med 2007; 4: e68. doi:10.1371/journal.pmed.0040068 (Pubitemid 46354444)
88. Hobday RA. Sunlight therapy and solar architecture. Med Hist 1997; 41: 455-72. doi:10.1017/S0025727300063043 (Pubitemid 127460527)
89. Page K, Wilson M, Parkin IP. Antimicrobial surfaces and their potential in reducing the role of the inanimate environment in the incidence of hospital-acquired infections. J Mater Chem 2009; 19: 3819-31. doi:10.1039/b818698g
90. Kent J. Using design to reduce cross infection. Nurs Times 2009; 105:
91. Doron S, Davidson LE. Antimicrobial stewardship. Mayo Clin Proc 2011; 86: 1113-23. doi:10.4065/mcp.2011.0358
92. Price DJ, Sleigh JD. Control of infection due to Klebsiella aerogenes in a neurosurgical unit by withdrawal of all antibiotics. Lancet 1970; 296: 1213-5. doi:10.1016/S0140-6736(70)92179-3
93. Garau J. Impact of antibiotic restrictions: the ethical perspective. Clin Microbiol Infect 2006; 12(Suppl. 5): 16-24.
94. Eggleston K, Zhang R, Zeckhauser RJ. The global challenge of antimicrobial resistance: insights from economic analysis. Int J Environ Res Public Health 2010; 7: 3141-9. doi:10.3390/ijerph7083141
95. Collignon P, Wegener HC, Braam P, Butler CD. The routine use of antibiotics to promote animal growth does little to benefit protein undernutrition in the developing world. Clin Infect Dis 2005; 41: 1007-13. doi:10.1086/433191 (Pubitemid 41368225)
96. Collignon P, Powers JH, Chiller TM, Aidara-Kane A, Aarestrup FM. World Health Organization ranking of antimicrobials according to their importance in human medicine: a critical step for developing risk management strategies for the use of antimicrobials in food production animals. Clin Infect Dis 2009; 49: 132-41. doi:10.1086/599374
97. Leggieri N, Rida A, Fraņcois P, Schrenzel J. Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside. Curr Opin Infect Dis 2010; 23: 311-9.
98. Kusano N. Hospital infection control in the 21st century-importance of network for hospital infection control and role of clinical laboratory. Rinsho Byori 2001; 49: 801-3.
99. Paterson DL, Doi Y.Astep closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis 2007; 45: 1179-81. doi:10.1086/522287 (Pubitemid 47580316)
100. Grundmann H, Klugman KP, Walsh T, Ramon-Pardo P, Sigauque B, Khan W, et al. A framework for global surveillance of antibiotic resistance. Drug Resist Updat 2011; 14: 79-87. doi:10.1016/j.drup. 2011.02.007
101. McNulty CA, Cookson BD, Lewis MA. Education of healthcare professionals and the public. J Antimicrob Chemother 2012; 67: i11-8. doi:10.1093/jac/dks199
102. Bloomfield SF. Gastrointestinal disease in the domestic setting: What are the Issues? J Infect 2001; 43: 23-9.
103. Parracho HM, Burrowes BH, Enright MC, McConville ML, Harper DR. The role of regulated clinical trials in the development of bacteriophage therapeutics. J Mol Genet Med 2012; 6: 279-86.
104. Abedon ST, Kuhl SJ, Blasdel BG, Kutter EM. Phage treatment of human infections. Bacteriophage 2011; 1: 66-85. doi:10.4161/bact.15845
105. Zhang L, Parente J, Harris SM, Woods DE, Hancock RE, Falla TJ. Antimicrobial peptide therapeutics for cystic fibrosis. Antimicrob Agents Chemother 2005; 49: 2921-7. doi:10.1128/AAC.49.7.2921-2927.2005 (Pubitemid 40917611)
106. Masuda Y, Zendo T, Sonomoto K. New type non-lantibiotic bacteriocins: circular and leaderless bacteriocins. Benef Microbes 2012; 3: 3-12. doi:10.3920/BM2011.0047
107. AokiW, Kuroda K, UedaM. Next generation of antimicrobial peptides as molecular targeted medicines. J Biosci Bioeng 2012; 114: 365-70. doi:10.1016/j.jbiosc.2012.05.001
108. Bibel DJ, Aly R, Bayles C, Strauss WG, Shinefield HR, Maibach HI. Competitive adherence as a mechanism of bacterial interference. Can J Microbiol 1983; 29: 700-3. doi:10.1139/m83-114 (Pubitemid 13050975)
109. van Delden C, Köhler T, Brunner-Ferber F, Fraņcois B, Carlet J, Pechère JC. Azithromycin to prevent Pseudomonas aeruginosa ventilator-associated pneumonia by inhibition of quorum sensing: a randomized controlled trial. Intensive Care Med 2012; 38: 1118-25. doi:10.1007/s00134-012- 2559-3
110. Guzman M, Dille J, Godet S. Synthesis and antibacterial activity of silver nanoparticles against gram-positive and gram-negative bacteria. Nanomedicine 2012; 8: 37-45. doi:10.1016/j.nano.2011.05.007
111. Carey BE, Dancer SJ. Reversing methicillin resistance in MRSA using a bacterial transforming agent. J Antimicrob Chemother 2006; 58: 455-7. doi:10.1093/jac/dkl245 (Pubitemid 44294966)
112. HiramatsuK, IgarashiM, Morimoto Y, Baba T, Umekita M, Akamatsu Y. Curing bacteria of antibiotic resistance: reverse antibiotics, a novel class of antibiotics in nature. Int J Antimicrob Agents 2012; 39: 478-85. doi:10.1016/j.ijantimicag.2012.02.007
113. Christaki E, Opal SM, Keith JC Jr, Kessimian N, Palardy JE, Parejo NA, et al. A monoclonal antibody against RAGE alters gene expression and is protective in experimental models of sepsis and pneumococcal pneumonia. Shock 2011; 35: 492-8. doi:10.1097/SHK.0b013e31820b2e1c
114. Roux D, Pier GB, Skurnik D. Magic bullets for the 21st century: the reemergence of immunotherapy for multi-and pan-resistant microbes. J Antimicrob Chemother 2012; 67: 2785-7. doi:10.1093/jac/dks335
115. Jaklic D, Lapanje A, Zupancic K, Smrke D, Gunde-Cimerman N. Selective antimicrobial activity of maggots against pathogenic bacteria. J Med Microbiol 2008; 57: 617-25. doi:10.1099/jmm.0.47515-0 (Pubitemid 351632910)
116. Carson CF, Hammer KA, Riley TV. Melaleuca alternifolia (Tea Tree) oil: a review of antimicrobial and other medicinal properties. Clin Microbiol Rev 2006; 19: 50-62. doi:10.1128/CMR.19.1.50-62.2006 (Pubitemid 43158450)
117. Wachtel-Galor S, Benzie IFF. Chapter 1. Herbal medicine: an introduction to its history, usage, regulation, current trends, and research needs. In: Benzie IFF, Wachtel-Galor S, eds. Herbal Medicine: Biomolecular and Clinical Aspects. 2nd edn. Boca Raton, FL: CRC Press; 2011.
118. Bhullar K, Waglechner N, Pawlowski A, Koteva K, Banks ED, Johnston MD, et al. Antibiotic resistance is prevalent in an isolated cave microbiome. PLoS ONE 2012; 7: e34 953. doi:10.1371/journal. pone.0034953
119. Haustein T, Gastmeier P, Holmes A, Lucet JC, Shannon RP, Pittet D, et al. Use of benchmarking and public reporting for infection control in four high-income countries. Lancet Infect Dis 2011; 11: 471-81. doi:10.1016/S1473- 3099(10)70315-7
120. Behnken S, Hertweck C. Anaerobic bacteria as producers of antibiotics. Appl Microbiol Biotechnol 2012; 96: 61-7. doi:10.1007/s00253-012-4285-8
121. Armellino D, Hussain E, Schilling ME, Senicola W, Eichorn A, Dlugacz Y, et al. Using high-technology to enforce low-technology safety measures: the use of third-party remote video auditing and real-time feedback in healthcare. Clin Infect Dis 2012; 54: 1-7. doi:10.1093/cid/cir773
122. Tang JW, Noakes CJ, Nielsen PV, Eames I, Nicolle A, Li Y, et al. Observing and quantifying airflows in the infection control of aerosoland airborne-transmitted diseases: an overview of approaches. J Hosp Infect 2011; 77: 213-22. doi:10.1016/j.jhin.2010.09.037
123. Sibley CD, Peirano G, Church DL. Molecular methods for pathogen and microbial community detection and characterization: current and potential application in diagnostic microbiology. Infect Genet Evol 2012; 12: 505-21. doi:10.1016/j.meegid.2012.01.011
124. Gibson TD, Hulbert JN, Prosser OC, Pavlou AK. Not to be sniffed at. Microbiol Today 2000; 27: 14-7.
125. Hegstad K, Langsrud S, Lunestad BT, Scheie AA, Sunde M, Yazdankhah SP. Does the wide use of quaternary ammonium compounds enhance the selection and spread of antimicrobial resistance and thus threaten our health? Microb Drug Resist 2010; 16: 91-104. doi:10.1089/mdr.2009.0120
126. Flanagan E, Chopra T, Mody L. Infection prevention in alternative health care settings. Infect Dis Clin North Am 2011; 25: 271-83. doi:10.1016/j.idc. 2010.11.008
127. Wiese-Posselt M, Heuck D, Draeger A, Mielke M, Witte W, Ammon A, et al. Successful termination of a furunculosis outbreak due to lukSlukF-positive, methicillin-susceptible Staphylococcus aureus in a German village by stringent decolonization, 2002-2005. Clin Infect Dis 2007; 44: e88-95. doi:10.1086/517503
128. Jit M, Stagg HR, Aldridge RW, White PJ, Abubakar I. Find and Treat Evaluation TeamDedicated outreach service for hard to reach patients with tuberculosis in London: observational study and economic evaluation. BMJ 2011; 343: d5376. doi:10.1136/bmj.d5376
129. Orand JP. Antimicrobial resistance and the standards of the World Organisation for Animal Health. Rev Sci Tech 2012; 31: 335-42, 325-34.
130. Collignon P. The importance of a One Health Approach to preventing the development and spread of antibiotic resistance. Curr Top Microbiol Immunoldoi:10.1007/82-2012-224In press
131. Domingues S, Harms K, Fricke WF, Johnsen PJ, da Silva GJ, Nielsen KM. Natural transformation facilitates transfer of transposons, integrons and gene cassettes between bacterial species. PLoS Pathog 2012; 8: e1002 837. doi:10.1371/journal.ppat.1002837
132. Wright GD. Antibiotic resistance in the environment: a link to the clinic? Curr Opin Microbiol 2010; 13: 589-94. doi:10.1016/j.mib. 2010.08.005
133. Salyers AA, Amábile-Cuevas CF. Why are antibiotic resistance genes so resistant to elimination? Antimicrob Agents Chemother 1997; 41: 2321-5. (Pubitemid 27467534)
134. Williamson DA, Sidjabat HE, Freeman JT, Roberts SA, Silvey A, Woodhouse R, et al. Identification and molecular characterisation of New Delhi metallo-b-lactamase-1 (NDM-1) and NDM-6-producing Enterobacteriaceae from New Zealand hospitals. Int J Antimicrob Agents 2012; 39: 529-33. doi:10.1016/j.ijantimicag.2012.02.017
135. Wellcome Collection. Dirt: The filthy reality of everyday life. London, UK: Wellcome Collection; 2011. Available from: http://www. wellcomecollection. org/whats-on/exhibitions/dirt.aspx [verified 22 March 2013]
136. Dancer SJ. Back to cleanliness [rapid response to: F. Godlee, Next to cleanliness]. BMJ 2008; 336: 0.1. Available from: http://www.bmj. com/rapid-response/2011/11/01/back-cleanliness [verified 22 March 2013]